Literature DB >> 24997724

Markers of poor outcome in patients with acute hypoxemic respiratory failure.

Won-Il Choi1, Esmeralda Shehu2, So Yeon Lim3, Shin Ok Koh4, Kyeongman Jeon3, Sungwon Na4, Chae-Man Lim5, Young-Joo Lee6, Seok Chan Kim7, Ick Hee Kim8, Je Hyeong Kim9, Jae Yeol Kim10, Jaemin Lim11, Chin Kook Rhee7, Sunghoon Park12, Ho Cheol Kim13, Jin Hwa Lee14, Ji Hyun Lee15, Jisook Park16, Younsuck Koh5, Gee Young Suh17.   

Abstract

PURPOSE: This study described the acute hypoxemic respiratory failure (AHRF) population and identified potential modifiable markers of outcome.
METHODS: A prospective, multicenter study was performed in 22 intensive care units (ICUs). The clinical outcomes of patients with acute respiratory distress syndrome (ARDS) were compared to the outcomes in patients with non-ARDS AHRF, and a propensity score matched analysis was performed.
RESULTS: A total 837 patients with an arterial oxygen tension/fraction of inspired oxygen ratio (Pao2/Fio2) less than 300 mm Hg on ICU admission were included. Of these, 163 patients met the criteria defining ARDS, whereas the remaining 674 patients who had unilateral or no pulmonary opacities were classified as non-ARDS AHRF. Baseline Pao2/Fio2 ratio, thrombocytopenia, increased positive end-expiratory pressure (PEEP) were significantly associated with the 60-day mortality in hypoxemic respiratory failure after multivariate analysis. However, ARDS was not associated with increased 60-day mortality when independent predictors for the 60-day mortality and propensity score were controlled. In the case-control study, the 60-day mortality rate was 38.6% in the ARDS group and 32.3% in the non-ARDS AHRF group. In both patients with ARDS and non-ARDS AHRF, the mortality rate increased proportionally to a lower baseline Pao2/Fio2.
CONCLUSION: Lower baseline oxygenation (Pao2/Fio2) is a poor prognostic marker in acute hypoxemic respiratory failure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARDS; Acute respiratory failure; Hypoxemia

Mesh:

Substances:

Year:  2014        PMID: 24997724     DOI: 10.1016/j.jcrc.2014.05.017

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  10 in total

1.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

2.  ARDS Clinical Practice Guideline 2021.

Authors:  Sadatomo Tasaka; Shinichiro Ohshimo; Muneyuki Takeuchi; Hideto Yasuda; Kazuya Ichikado; Kenji Tsushima; Moritoki Egi; Satoru Hashimoto; Nobuaki Shime; Osamu Saito; Shotaro Matsumoto; Eishu Nango; Yohei Okada; Kenichiro Hayashi; Masaaki Sakuraya; Mikio Nakajima; Satoshi Okamori; Shinya Miura; Tatsuma Fukuda; Tadashi Ishihara; Tetsuro Kamo; Tomoaki Yatabe; Yasuhiro Norisue; Yoshitaka Aoki; Yusuke Iizuka; Yutaka Kondo; Chihiro Narita; Daisuke Kawakami; Hiromu Okano; Jun Takeshita; Keisuke Anan; Satoru Robert Okazaki; Shunsuke Taito; Takuya Hayashi; Takuya Mayumi; Takero Terayama; Yoshifumi Kubota; Yoshinobu Abe; Yudai Iwasaki; Yuki Kishihara; Jun Kataoka; Tetsuro Nishimura; Hiroshi Yonekura; Koichi Ando; Takuo Yoshida; Tomoyuki Masuyama; Masamitsu Sanui
Journal:  J Intensive Care       Date:  2022-07-08

3.  Examination of the Ability of N-acetylcysteine Administration during Anesthesia to Prevent Perioperative Deterioration of Pulmonary Function in Patients Undergoing Nephrectomy.

Authors:  Dea Ja Um; Seok-Joo Hong; Jong Taek Park
Journal:  J Lifestyle Med       Date:  2014-09-30

4.  Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets.

Authors:  Chih-Hung Chen; Yung-Lung Chen; Pei-Hsun Sung; Cheuk-Kwan Sun; Kuan-Hung Chen; Yi-Ling Chen; Tien-Hung Huang; Hung-I Lu; Fan-Yen Lee; Jiunn-Jye Sheu; Sheng-Ying Chung; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-07-17

5.  Shock Wave Therapy Enhances Mitochondrial Delivery into Target Cells and Protects against Acute Respiratory Distress Syndrome.

Authors:  Kun-Chen Lin; Christopher Glenn Wallace; Tsung-Cheng Yin; Pei-Hsun Sung; Kuan-Hung Chen; Hung-I Lu; Han-Tan Chai; Chih-Hung Chen; Yi-Ling Chen; Yi-Chen Li; Pei-Lin Shao; Mel S Lee; Jiunn-Jye Sheu; Hon-Kan Yip
Journal:  Mediators Inflamm       Date:  2018-10-21       Impact factor: 4.711

6.  Peritoneal Membrane Oxygenation Therapy for Rats With Acute Respiratory Distress Syndrome.

Authors:  Nathan Legband; Liana Hatoum; Alec Thomas; Craig Kreikemeier-Bower; Douglas Hostetler; Keely Buesing; Mark Borden; Benjamin Terry
Journal:  J Med Device       Date:  2016-05-12       Impact factor: 0.582

7.  Epidemiology, Mechanical Power, and 3-Year Outcomes in Acute Respiratory Distress Syndrome Patients Using Standardized Screening. An Observational Cohort Study.

Authors:  Ken Kuljit S Parhar; Karolina Zjadewicz; Andrea Soo; Alan Sutton; Margaret Zjadewicz; Lauren Doig; Calvin Lam; Andre Ferland; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Christopher J Doig
Journal:  Ann Am Thorac Soc       Date:  2019-10

8.  Association between SpO2/FiO2 Ratio and PaO2/FiO2 Ratio in Different Modes of Oxygen Supplementation.

Authors:  Sheetal Babu; Kundavaram Pp Abhilash; Subramani Kandasamy; Mahasampath Gowri
Journal:  Indian J Crit Care Med       Date:  2021-09

9.  Association Between Peripheral Blood Oxygen Saturation (SpO2)/Fraction of Inspired Oxygen (FiO2) Ratio Time at Risk and Hospital Mortality in Mechanically Ventilated Patients.

Authors:  Jason Y Adams; Angela J Rogers; Alejandro Schuler; Gregory P Marelich; Jennifer M Fresco; Sandra L Taylor; Albert W Riedl; Jennifer M Baker; Gabriel J Escobar; Vincent X Liu
Journal:  Perm J       Date:  2020-01-31

10.  [Severity of disease scoring systems and mortality after non-cardiac surgery].

Authors:  Pedro Videira Reis; Gabriela Sousa; Ana Martins Lopes; Ana Vera Costa; Alice Santos; Fernando José Abelha
Journal:  Braz J Anesthesiol       Date:  2018-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.